SuperworthAnnexon market cap ANNX
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $710.9M
- Highest close in our data
- $1.3B
- Mar 2021
Annexon is worth $710.9M at the close on Oct 23, 2026, at $3.75 a share.
That is up 102% over the last year and up 14% over five years.
Its highest close in our data was $1.3B in Mar 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $710.9M | $561.1M | $1B | +16% |
| 2025 | $611.3M | $160.2M | $618.5M | +11% |
| 2024 | $553.2M | $214.6M | $790.3M | +129% |
| 2023 | $241.7M | $86.8M | $355.3M | −2% |
| 2022 | $246.2M | $83.7M | $329.3M | −44% |
| 2021 | $440.9M | $440.9M | $1.3B | −54% |
| 2020 | $955.1M | $793.9M | $1.2B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Annexon's size, closest first, today.
| Company | Market cap |
|---|---|
| ANNXAnnexon | $710.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| CRMDCorMedix | $611.9M |
| ABUSArbutus Biopharma | $831M |
| ZVRAZevra Therapeutics | $582.6M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| PBYIPuma Biotechnology | $568.9M |
| ARVNArvinas | $477.3M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.2B |
| PCRXPacira BioSciences | $1.5B |
| Peer median | $679.7M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Annexon
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.